FDA grants fast track status to Verastem's lung cancer drug VS-7375

June 3, 2026 4:01 PM

Verastem Oncology (NASDAQ: VSTM) received Fast Track Designation from the U.S. Food and Drug Administration for VS-7375, an oral investigational ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found